A Study of AK112 as Consolidation Treatment for Patients With Limited Stage Small-cell Lung Cancer Who Have Not Progressed Following Concurrent Chemoradiation Therapy

Abroad (travel likely)RecruitingPHASE3

Conditions

Small Cell Lung Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Beijing Cancer Hospital, Beijing, Beijing Municipality, China

    Contact: Study coordinator (Rong Yu, M.D.)
    Contact: Principal Investigator (Rong Yu, M.D.)
  • The First Medical Center of Chinese PLA General Hospital, Beijing, Beijing Municipality, China

    Contact: Study coordinator (Yi Hu, M.D.)
    Contact: Principal Investigator (Yi Hu, M.D.)
  • Beijing Chest Hospital, Beijing, Beijing Municipality, China

    Contact: Study coordinator (Gen Lin, M.D.)
    Contact: Principal Investigator (Gen Lin, M.D.)
  • Beijing Luhe Hospital, Capital Medical University, Beijing, Beijing Municipality, China

    Contact: Study coordinator (Dong Yan, M.D.)
    Contact: Principal Investigator (Dong Yan, M.D.)
  • Cancer Hospital, Chinese Academy of Medical Sciences, Beijin, Beijin, China

    Contact: Study coordinator (Zhijie Wang, M.D.)
    Contact: Principal Investigator (Zhijie Wang, M.D.)
  • The First Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing Municipality, China

    Contact: Study coordinator (Ge Luo, M.D.)
    Contact: Principal Investigator (Ge Luo, M.D.)
  • Fujian Cancer Hospital, Fuzhou, Fujian, China

    Contact: Study coordinator (Haipeng Xu, M.D.)
    Contact: Principal Investigator (Haipeng Xu, M.D.)
  • PLA No. 900 Hospital of the Joint Support Force, Fuzhou, Fujian, China

    Contact: Study coordinator (Zongyang Yu, M.D.)
    Contact: Principal Investigator (Zongyang Yu, M.D.)
  • Longyan First Hospital, Longyan, Fujian, China

    Contact: Study coordinator (Chunyue Wang, M.D.)
    Contact: Principal Investigator (Chunyue Wang, M.D.)
  • Zhangzhou Municipal Hospital of Fujian Province, Zhangzhou, Fujian, China

    Contact: Study coordinator (Li Lin, M.D.)
    Contact: Principal Investigator (Li Lin, M.D.)
  • Gansu Provincial Cancer Hospital, Lanzhou, Gansu, China

    Contact: Study coordinator (Shihong Wei, M.D.)
    Contact: Principal Investigator (Shihong Wei, M.D.)
  • Jiangmen Central Hospital, Jiangmen, Guangdong, China

    Contact: Study coordinator (Gengsheng Yu, M.D.)
    Contact: Principal Investigator (Gengsheng Yu, M.D.)
  • Liuzhou People's Hospital, Liuzhou, Guangxi, China

    Contact: Study coordinator (Leili Wang, M.D.)
    Contact: Principal Investigator (Leili Wang, M.D.)
  • Affiliated Cancer Hospital of Guangxi Medical University, Nanning, Guangxi, China

    Contact: Study coordinator (Jiangqiong Huang, M.D.)
    Contact: Principal Investigator (Jiangqiong Huang, M.D.)
  • The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China

    Contact: Study coordinator (Qing Bu, M.D.)
    Contact: Principal Investigator (Qing Bu, M.D.)
  • Guangdong Provincial People's Hospital, Guangzhou, Guangzhou, China

    Contact: Study coordinator (Jing Li, M.D.)
    Contact: Principal Investigator (Jing Li, M.D.)
  • Guizhou Provincial People's Hospital, Guiyang, Guizhou, China

    Contact: Study coordinator (Yu Zhang, M.D.)
    Contact: Principal Investigator (Yu Zhang, M.D.)
  • The Second Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China

    Contact: Study coordinator (Shiyun Xing, M.D.)
    Contact: Principal Investigator (Shiyun Xing, M.D.)
  • The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China

    Contact: Study coordinator (Jun Wang, M.D.)
    Contact: Principal Investigator (Jun Wang, M.D.)
  • Tangshan People's Hospital, Tangshan, Hebei, China

    Contact: Study coordinator (Zhiwu Wang, M.D.)
    Contact: Principal Investigator (Zhiwu Wang, M.D.)
    Contact: Principal Investigator (Guilan Dong, M.D.)
  • Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China

    Contact: Study coordinator (Yan Yu, M.D.)
    Contact: Principal Investigator (Yan Yu, M.D.)
  • The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China

    Contact: Study coordinator (Yu Yang, M.D.)
    Contact: Principal Investigator (Yu Yang, M.D.)
  • Anyang Cancer Hospital, Anyang, Henan, China

    Contact: Study coordinator (Anping Zheng, M.D.)
    Contact: Principal Investigator (Anping Zheng, M.D.)
  • The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, China

    Contact: Study coordinator (Qingqin Zhang, M.D.)
    Contact: Principal Investigator (Qingqin Zhang, M.D.)
  • Henan Cancer Hospital, Zhengzhou, Henan, China

    Contact: Study coordinator (Yanqiu Zhao, M.D.)
    Contact: Principal Investigator (Yanqiu Zhao, M.D.)
  • Jingzhou First People's Hospital, Jingzhou, Hubei, China

    Contact: Study coordinator (Yonghua Yang, M.D.)
    Contact: Principal Investigator (Yonghua Yang, M.D.)
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

    Contact: Study coordinator (Xiaorong Dong, M.D.)
    Contact: Principal Investigator (Xiaorong Dong, M.D.)
  • Hunan Cancer Hospital, Changsha, Hunan, China

    Contact: Study coordinator (Yongzhong Luo, M.D.)
    Contact: Principal Investigator (Yongzhong Luo, M.D.)
  • Hunan Cancer Hospital, Changsha, Hunan, China

    Contact: Study coordinator (Lin Wu, M.D.)
    Contact: Principal Investigator (Lin Wu, M.D.)
    Contact: Principal Investigator (Huai Liu, M.D.)
  • The First Affiliated Hospital of South China University, Hengyang, Hunan, China

    Contact: Study coordinator (Yuehua Li, M.D.)
    Contact: Principal Investigator (Yuehua Li, M.D.)
  • General Hospital of the PLA Eastern Theater Command, Nanjing, Jiangsu, China

    Contact: Study coordinator (Xiangfeng Lv, M.D.)
    Contact: Principal Investigator (Xiangfeng Lv, M.D.)
  • Jiangsu Cancer Hospital, Nanjing, Jiangsu, China

    Contact: Study coordinator (Lin Shi, M.D.)
    Contact: Principal Investigator (Lin Shi, M.D.)
  • Xuzhou Municipal Hospital, Xuzhou, Jiangsu, China

    Contact: Study coordinator (Haitao Yin, M.D.)
    Contact: Principal Investigator (Haitao Yin, M.D.)
  • The First Affiliated Hospital of Gannan Medical University, Gannan, Jiangxi, China

    Contact: Study coordinator (Jie Li, M.D.)
    Contact: Principal Investigator (Jie Li, M.D.)
  • The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China

    Contact: Study coordinator (Longhua Sun, M.D.)
    Contact: Principal Investigator (Longhua Sun, M.D.)
  • Jilin Cancer Hospital, Changchun, Jilin, China

    Contact: Study coordinator (Haifeng Liu, M.D.)
    Contact: Principal Investigator (Haifeng Liu, M.D.)
  • The First Hospital of China Medical University, Shenyang, Liaoning, China

    Contact: Study coordinator (Bo Jin, M.D.)
    Contact: Principal Investigator (Bo Jin, M.D.)
  • Ningxia Medical University General Hospital, Yinchuan, Ningxia, China

    Contact: Study coordinator (Yanyang Wang, M.D.)
    Contact: Principal Investigator (Yanyang Wang, M.D.)
  • Shandong Provincial Hospital, Jinan, Shandong, China

    Contact: Study coordinator (Zhe Yang, M.D.)
    Contact: Principal Investigator (Zhe Yang, M.D.)
  • Shandong Cancer Hospital, Jinan, Shandong, China

    Contact: Study coordinator (Hui Zhu, M.D.)
    Contact: Principal Investigator (Hui Zhu, M.D.)
  • Linyi Cancer Hospital, Linyi, Shandong, China

    Contact: Study coordinator (Jianhua Shi, M.D.)
    Contact: Principal Investigator (Jianhua Shi, M.D.)
  • Linyi People's Hospital, Linyi, Shandong, China

    Contact: Study coordinator (Zhongmin Zhang, M.D.)
    Xueliang Xu, M.D. (Sub-investigator)
    Contact: Principal Investigator (Zhongmin Zhang, M.D.)
  • Qingdao Central Hospital of Health and Rehabilitation Sciences University, Qingdao, Shandong, China

    Contact: Study coordinator (Zhen Zhang, M.D.)
    Contact: Study coordinator (Xiaotao Zhang, M.D.)
    Contact: Principal Investigator (Zhen Zhang, M.D.)
    Contact: Principal Investigator (Xiaotao Zhang, M.D.)
  • Zaozhuang Municipal Hospital, Zaozhuang, Shandong, China

    Contact: Study coordinator (Shifeng Kan, M.D.)
    Contact: Principal Investigator (Shifeng Kan, M.D.)
  • Weifang No.2 People's Hospital, Weifang, Shangdong, China

    Contact: Study coordinator (Kunning Yang, M.D.)
    Contact: Principal Investigator (Kunning Yang, M.D.)
  • Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality, China

    Contact: Study coordinator (Zhengfei Zhu, M.D.)
    Contact: Principal Investigator (Zhengfei Zhu, M.D.)
  • Shanghai Pulmonary Hospital, Shanghai, Shanghai Municipality, China

    Contact: Study coordinator (Fengying Wu, M.D.)
    Contact: Principal Investigator (Fengying Wu, M.D.)
  • Shanxi Cancer Hospital, Taiyuan, Shanxi, China

    Contact: Study coordinator (Hongwei Li, M.D.)
    Contact: Principal Investigator (Hongwei Li, M.D.)
  • Tangdu Hospital, The Fourth Military Medical University, Xi’an, Shanxi, China

    Contact: Study coordinator (Xiaolong Yan, M.D.)
    Contact: Principal Investigator (Xiaolong Yan, M.D.)
  • Mianyang Central Hospital, Mianyang, Sichuan, China

    Contact: Study coordinator (Xiaobo Du, M.D.)
    Contact: Principal Investigator (Xiaobo Du, M.D.)
  • Tianjin Cancer Hospital, Tianjin, Tianjin Municipality, China

    Contact: Study coordinator (Dingzhi Huang, M.D.)
    Contact: Principal Investigator (Dingzhi Huang, M.D.)
  • The First Affiliated Hospital of Xi'an Jiaotong University, Shaxi, Xi'an, China

    Contact: Study coordinator (Yu Yao, M.D.)
    Contact: Principal Investigator (Yu Yao, M.D.)
  • The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China

    Contact: Study coordinator (Yuping Li, M.D.)
    Contact: Principal Investigator (Yuping Li, M.D.)